Earnings snapshot: Hims & Hers Health Q1 earnings hit by margin pressure; lifts Q2 revenue More on Hims & Hers Health Hims Earnings: Stability Could Trigger A Squeeze Hims & Hers, Novo Nordisk: FDA…
Hims & Hers Health (NYSE:HIMS) Misses Q1 2026 Estimates, Shares Drop on GLP-1 Pivot Costs Hims & Hers Health (HIMS) missed Q1 2026 estimates, with revenue of $608.1M and an adjusted loss of $0.18 per…
Hims & Hers Health (NYSE:HIMS) Misses Q1 CY2026 Sales Expectations, Stock Drops 11.5% Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.…
Why Hims & Hers Health Are Falling Monday - Hims & Hers Health (NYSE:HIMS) Hims & Hers Health report Q1 results, missing revenue estimates but increasing subscribers. Stock drops more than 9% in after-hours…
Hims & Hers (HIMS) Q1 2026: EPS -$0.40 vs $0.04 est (miss), Revenue $608.1M vs $616.85M (miss) -- Still 21.1% Undervalued? GF Score 80/100 Subscriber base nears 2.6 million as international expansion offsets U.S. softness; margins compress, free cash flow positive…
HIMS Earnings: Hims & Hers Stock Falls 10% as Financial Results Miss Wall Street Targets The stock of Hims Hers Health ($HIMS) fell as much as 10% in after-hours trading as the telehealth company…
HIMS: Net loss of $92.1M on $608.1M revenue, with strong international growth but U.S. decline Revenue grew 4% year-over-year to $608.1M, driven by international expansion, but net loss was $92.1M due to restructuring charges and…
Hims & Hers Stock Sinks. Why Earnings Offered Wall Street a Big Surprise. Hims & Hers shares are falling after reporting disappointing first-quarter earnings results.…
Hims Sales Miss on Rising Competition for Weight-Loss Drugs Hims & Hers Health Inc. reported a first-quarter loss and sales that missed Wall Street estimates amid increasing competition in…
Hims’ Pivot to Branded Obesity Drugs Comes With Rising Costs Hims & Hers Health Inc. reported a first-quarter loss and sales that missed Wall Street estimates as it faces higher…
Hims & Hers Health (NYSE:HIMS) Misses Q1 CY2026 Sales Expectations, Stock Drops 11.5% Telehealth company Hims & Hers Health (NYSE:HIMS) missed Wall Street’s revenue expectations in Q1 CY2026 as sales rose 3.8% year…
Hims & Hers Health (NYSE:HIMS) Misses Q1 CY2026 Sales Expectations, Stock Drops 11.5% Telehealth company Hims & Hers Health (NYSE:HIMS) missed Wall Street’s revenue expectations in Q1 CY2026 as sales rose 3.8% year…